"Kantonsspital Baselland Liestal..."

During the past decade, Kantonsspital Liestal conducted 33 clinical trials. In the 10-year time frame, 33 clinical trials started and 1 clinical trials were completed, i.e. on average, 3% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 1 clinical trials were completed. i.e. 6.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kantonsspital Liestal" #1 sponsor was "Swiss Group for Clinical Cancer Research" with 30 trials, followed by "Prof. Dr. Jörg Leuppi" with 4 trials sponsored, "Fondazione Epatocentro Ticino" with 3 trials sponsored, "Kantonsspital Liestal" with 2 trials sponsored and "Terumo Europe N.V." with 2 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kantonsspital Liestal" #1 collaborator was "AstraZeneca" with 2 trials as a collaborator, "Kantonsspital Liestal" with 2 trials as a collaborator, "University of Lausanne Hospitals" with 2 trials as a collaborator, "AGO Study Group" with 1 trials as a collaborator and "Anticancer Fund, Belgium" with 1 trials as a collaborator. Other collaborators include 41 different institutions and companies that were collaborators in the rest 51 trials.

According to Clinical.Site data, the most researched conditions in "Kantonsspital Liestal" are "Lung Cancer" (4 trials), "Lymphoma" (4 trials), "Breast Cancer" (3 trials), "Esophageal Cancer" (3 trials) and "Prostate Cancer" (3 trials). Many other conditions were trialed in "Kantonsspital Liestal" in a lesser frequency.

Most popular intervention types in "Kantonsspital Liestal" are "Drug" (37 trials), "Biological" (9 trials), "Other" (9 trials), "Procedure" (8 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Ibrutinib" (4 trials), "Radiotherapy" (3 trials), "cetuximab" (3 trials) and "cisplatin" (3 trials). Other intervention names were less common.

The vast majority of trials in "Kantonsspital Liestal" are 50 trials for "All" genders, 7 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Kantonsspital Liestal". undefined are not yet recruiting, 12 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 28 completed trials in Kantonsspital Liestal, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Kantonsspital Liestal, 2 "Phase 1" clinical trials were conducted, 23 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 6 trials that are defined as “Not Applicable".

Kantonsspital Liestal has several departments that took part in Clinical trials: "Kantonsspital Baselland (Bruderholz, Liestal, Laufen), Department of Orthopaedic Surgery and Traumatology" - 2 trials